4 Comments

Summary:

Venture firms, particularly Khosla Ventures, can’t get enough of biofuels. Amyris Biotechnologies, an Emeryville-based synthetic biology start-up that develops a fermentation process to produce biofuels, just landed the first part of $70 million in VC backing from DAG Ventures, Khosla Ventures, Kleiner Perkins, and TPG Ventures, […]

amyris1.jpgVenture firms, particularly Khosla Ventures, can’t get enough of biofuels. Amyris Biotechnologies, an Emeryville-based synthetic biology start-up that develops a fermentation process to produce biofuels, just landed the first part of $70 million in VC backing from DAG Ventures, Khosla Ventures, Kleiner Perkins, and TPG Ventures, according to the Contra Costa Times. Update: Here’s the company’s press release this morning.

The company is developing biofuels to replace gas, diesel and jetfuel. According to the Times the release, the funding will be used to help the company bring these fuels to market by 2010. Amyris previously raised $20 million Series A Funding in October of 2006 led by Khosla Ventures. We contacted the company and will add more details when we learn more.

Recently there’s been a rush of venture funding into biofuel startups, as companies are struggling to develop the next-generation of more efficient and cost-effective environmentally friendly fuels. Propel Biofuels, Virent, Endicott, Galten, and Terrabon all raised funding in the past few weeks.
The Canadian government also launched a roughly $500 million fund to jump-start the development and production of next generation biofuels in Canada.

By Adena DeMonte

You're subscribed! If you like, you can update your settings

Related stories

  1. [...] the U.S. transportation system. Still, the area has received relatively little investor interest. Amyris has mentioned jet fuel, although gas for cars remains their focus in the near term. Kerosene, which is what powers jets, [...]

    Share
  2. [...] a startup using synthetic biology to replace petroleum, has added another $21 million to its already sizable $70 million funding round. This brings the total for its ongoing series B round to $91.35 million. The company confirmed the [...]

    Share
  3. [...] light.” The company has raised more than $120 million in capital (see previous coverage here and here) from heavy-hitting cleantech and biotech investors, including Kleiner Perkins, Khosla [...]

    Share
  4. [...] by June 2010, is raising a Series C round of $62 million, according to PeHub.com. The company has previously raised over $120 million from investors like Khosla Ventures, Kleiner Perkins Caufield & Byers, and [...]

    Share

Comments have been disabled for this post